According to the American College of Medical Genetics and Genomics guidelines (15), this heterozygous GCM2 frameshift variant was classified as pathogenic (PVS1+PS2+PM2) and determined to be the cause of hypoparathyroidism in this patient. The gene discussed is GCM2; the disease is hypoparathyroidism.